Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer
Authors:
- Mohamed HebbarMHMohamed Hebbar
- François-René PruvotFPFrançois-René Pruvot
- Olivier RomanoOROlivier Romano
- Jean-Pierre TribouletJTJean-Pierre Triboulet
- Aimery de GramontAGAimery de Gramont
- 1 December 2009
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 35 (8) , 668-675
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II studyBMC Cancer, 2009
- A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin in Previously Untreated Patients with Metastatic Colorectal CancerClinical Cancer Research, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activationBritish Journal of Cancer, 2007
- Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc +/min miceProceedings of the National Academy of Sciences, 2007
- Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2006
- Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal CarcinomaJournal of Clinical Oncology, 2005
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastasesBritish Journal of Surgery, 2001
- Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] MetastasesAnnals of Surgical Oncology, 2001